Significance of inducible ventricular flutter-fibrillation after myocardial infarction

Pacing Clin Electrophysiol. 2005 Sep;28(9):938-43. doi: 10.1111/j.1540-8159.2005.00193.x.

Abstract

Aim: The purpose of this study was to determine the factors associated with the induction of ventricular flutter/fibrillation (VFl/VF)and its prognostic significance in post-myocardial infarction.

Methods: Programmed ventricular stimulation was performed after myocardial infarction (MI) for syncope (n = 232) or systematically (n = 755); 230 patients had an induced VFl/VF and were followed during 4 +/- 2 years.

Results: VFl/VF was induced in 49/232 patients (21%) with syncope versus 181/755 asymptomatic patients (24%) (NS) and 94/410 patients (23%) with left ventricular ejection fraction (LVEF) <40% versus 136/577 patients (22.5%) with LVEF >40% (NS). Cardiac mortality was 9%; LVEF was 33 +/- 15% in patients who died, 43 +/- 13% in alive patients (P < 0.004). In patients with LVEF <40%, induced VFl/VF, mortality rate was 31% in those with syncope, 10% in asymptomatic patients (P < 0.001), because of an increase of deaths by heart failure; patients with LVEF >40% with or without syncope had a low mortality (5% and 3%). After linear logistic regression, VFl/VF and LVEF were predictors of total cardiac mortality, but only LVEF <40% predicted sudden death.

Conclusion: Syncope and the level of LVEF did not increase the incidence of VFl/VF induction after MI, but modified the cardiac mortality: induced VF increased total cardiac mortality in patients with syncope and LVEF <40%, but did not increase sudden death. In patients with LVEF >40%, induced VFl/VF has no significance neither in asymptomatic patients nor in those with syncope.

MeSH terms

  • Chi-Square Distribution
  • Death, Sudden, Cardiac / prevention & control
  • Defibrillators, Implantable*
  • Female
  • Humans
  • Male
  • Myocardial Infarction / complications*
  • Outcome Assessment, Health Care
  • Prognosis
  • Regression Analysis
  • Syncope / mortality
  • Syncope / therapy*
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / mortality
  • Tachycardia, Ventricular / therapy*
  • Ventricular Fibrillation / etiology
  • Ventricular Fibrillation / mortality
  • Ventricular Fibrillation / therapy*